Evaluation of nanoparticle tracking analysis for total virus particle determination
The NanoSight LM10 with Nanoparticle tracking analysis (NTA) software was evaluated for the quantification of latex particles, adenovirus 5, and influenza virus. The inter-day variability was determined by measuring the same sample over several consecutive days and the method’s accuracy was demonstr...
Saved in:
| Published in | Virology journal Vol. 9; no. 1; p. 265 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
12.11.2012
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1743-422X 1743-422X |
| DOI | 10.1186/1743-422X-9-265 |
Cover
| Abstract | The NanoSight LM10 with Nanoparticle tracking analysis (NTA) software was evaluated for the quantification of latex particles, adenovirus 5, and influenza virus. The inter-day variability was determined by measuring the same sample over several consecutive days and the method’s accuracy was demonstrated by using known concentrations of the subject particles. NTA analysis was also used to quantify chromatographic fractions of adenovirus and influenza virus after purification on a CIM monolithic column. NTA results were compared and evaluated against hemagglutination (HA) and end point dilution assay, determining total and infection virus particle number, respectively. The results demonstrated that nanoparticle tracking analysis is a method for fast estimation of virus concentration in different samples. In addition, it can provide a better insight into the sample status, regarding the level of virus aggregation. |
|---|---|
| AbstractList | The NanoSight LM10 with Nanoparticle tracking analysis (NTA) software was evaluated for the quantification of latex particles, adenovirus 5, and influenza virus. The inter-day variability was determined by measuring the same sample over several consecutive days and the method’s accuracy was demonstrated by using known concentrations of the subject particles. NTA analysis was also used to quantify chromatographic fractions of adenovirus and influenza virus after purification on a CIM monolithic column. NTA results were compared and evaluated against hemagglutination (HA) and end point dilution assay, determining total and infection virus particle number, respectively. The results demonstrated that nanoparticle tracking analysis is a method for fast estimation of virus concentration in different samples. In addition, it can provide a better insight into the sample status, regarding the level of virus aggregation. The NanoSight LM10 with Nanoparticle tracking analysis (NTA) software was evaluated for the quantification of latex particles, adenovirus 5, and influenza virus. The inter-day variability was determined by measuring the same sample over several consecutive days and the method's accuracy was demonstrated by using known concentrations of the subject particles. NTA analysis was also used to quantify chromatographic fractions of adenovirus and influenza virus after purification on a CIM monolithic column. NTA results were compared and evaluated against hemagglutination (HA) and end point dilution assay, determining total and infection virus particle number, respectively. The results demonstrated that nanoparticle tracking analysis is a method for fast estimation of virus concentration in different samples. In addition, it can provide a better insight into the sample status, regarding the level of virus aggregation. Keywords: NanoSight, NTA, Adenovirus 5, Influenza, Latex particles, CIM monolithic column The NanoSight LM10 with Nanoparticle tracking analysis (NTA) software was evaluated for the quantification of latex particles, adenovirus 5, and influenza virus. The inter-day variability was determined by measuring the same sample over several consecutive days and the method's accuracy was demonstrated by using known concentrations of the subject particles. NTA analysis was also used to quantify chromatographic fractions of adenovirus and influenza virus after purification on a CIM monolithic column. NTA results were compared and evaluated against hemagglutination (HA) and end point dilution assay, determining total and infection virus particle number, respectively. The results demonstrated that nanoparticle tracking analysis is a method for fast estimation of virus concentration in different samples. In addition, it can provide a better insight into the sample status, regarding the level of virus aggregation.The NanoSight LM10 with Nanoparticle tracking analysis (NTA) software was evaluated for the quantification of latex particles, adenovirus 5, and influenza virus. The inter-day variability was determined by measuring the same sample over several consecutive days and the method's accuracy was demonstrated by using known concentrations of the subject particles. NTA analysis was also used to quantify chromatographic fractions of adenovirus and influenza virus after purification on a CIM monolithic column. NTA results were compared and evaluated against hemagglutination (HA) and end point dilution assay, determining total and infection virus particle number, respectively. The results demonstrated that nanoparticle tracking analysis is a method for fast estimation of virus concentration in different samples. In addition, it can provide a better insight into the sample status, regarding the level of virus aggregation. Doc number: 265 Abstract: The NanoSight LM10 with Nanoparticle tracking analysis (NTA) software was evaluated for the quantification of latex particles, adenovirus 5, and influenza virus. The inter-day variability was determined by measuring the same sample over several consecutive days and the method's accuracy was demonstrated by using known concentrations of the subject particles. NTA analysis was also used to quantify chromatographic fractions of adenovirus and influenza virus after purification on a CIM monolithic column. NTA results were compared and evaluated against hemagglutination (HA) and end point dilution assay, determining total and infection virus particle number, respectively. The results demonstrated that nanoparticle tracking analysis is a method for fast estimation of virus concentration in different samples. In addition, it can provide a better insight into the sample status, regarding the level of virus aggregation. Abstract The NanoSight LM10 with Nanoparticle tracking analysis (NTA) software was evaluated for the quantification of latex particles, adenovirus 5, and influenza virus. The inter-day variability was determined by measuring the same sample over several consecutive days and the method’s accuracy was demonstrated by using known concentrations of the subject particles. NTA analysis was also used to quantify chromatographic fractions of adenovirus and influenza virus after purification on a CIM monolithic column. NTA results were compared and evaluated against hemagglutination (HA) and end point dilution assay, determining total and infection virus particle number, respectively. The results demonstrated that nanoparticle tracking analysis is a method for fast estimation of virus concentration in different samples. In addition, it can provide a better insight into the sample status, regarding the level of virus aggregation. |
| ArticleNumber | 265 |
| Audience | Academic |
| Author | Štrancar, Aleš Peterka, Matjaž Kramberger, Petra Ciringer, Mateja |
| AuthorAffiliation | 1 BIA Separations, d.o.o, Mirce 21, SI-5270, Ajdovščina, Slovenia 2 CO-BIK, Velika pot 22, SI-5250, Solkan, Slovenia |
| AuthorAffiliation_xml | – name: 1 BIA Separations, d.o.o, Mirce 21, SI-5270, Ajdovščina, Slovenia – name: 2 CO-BIK, Velika pot 22, SI-5250, Solkan, Slovenia |
| Author_xml | – sequence: 1 givenname: Petra surname: Kramberger fullname: Kramberger, Petra email: petra.kramberger@monoliths.com organization: BIA Separations, CO-BIK – sequence: 2 givenname: Mateja surname: Ciringer fullname: Ciringer, Mateja organization: CO-BIK – sequence: 3 givenname: Aleš surname: Štrancar fullname: Štrancar, Aleš organization: BIA Separations, CO-BIK – sequence: 4 givenname: Matjaž surname: Peterka fullname: Peterka, Matjaž organization: BIA Separations, CO-BIK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23140220$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFks9v2yAYhq2p0_pjO-82WdplO7gFDDZcJlVVt0WqNGntYTcEBDwyBzLA0frfDydpFlerKh9s4ed9BB_vaXHkvNNF8RaCcwhpcwFbXFcYoR8Vq1BDXhQn-5Wjg-_j4jTGBQA1alr2qjhGNcQAIXBS3F6vRT-IZL0rvSmdcH4lQrKq12UKQv2yriuFE_19tLE0PpTJJ9GXaxuGWO7RuU46LK3biF4XL43oo36ze58Vd5-v766-VjffvsyuLm8q1TYwVRhIbZgkSEMKAWVSYNxKplqKgKSYYqAokAxLzDQFGFFKWkWN0lIhU8_rs2K21c69WPBVsEsR7rkXlm8WfOj4bnscKKGNwgAipbHWRBrGECYEywYIZGB2fdq6VoNc6rnSLh--n0inf5z9yTu_5jUBdYNoFnzYCYL_PeiY-NJGpfteOO2HyBGjBLd127BnUVgjSiAmjDyPQtbmQVE2Wt8_Qhd-CPniRqplAJAM_aM6kcdinfHjJY9SfklqXAMA6eg6_w-Vn7leWpUbaGxenwQ-TgKZSfpP6sQQI5_dfp-y7w5HvZ_xQyczQLaACj7GoA1XNm2KlXdhew4BH7vPx3bzsd2c8dz9nLt4lHtQP50A20TMpOt0OJjZE5G_dq8R_g |
| CitedBy_id | crossref_primary_10_1021_acs_jpcc_5b03634 crossref_primary_10_1016_j_colsurfb_2022_112716 crossref_primary_10_1039_C8SM01269E crossref_primary_10_3389_fmicb_2016_01500 crossref_primary_10_1016_j_bioactmat_2021_06_001 crossref_primary_10_1016_j_jaerosci_2023_106199 crossref_primary_10_1039_D1LC00709B crossref_primary_10_3390_nano11061394 crossref_primary_10_1021_acs_est_9b07727 crossref_primary_10_1038_s41598_022_19744_x crossref_primary_10_3390_ijms22052409 crossref_primary_10_1016_j_jconrel_2016_06_022 crossref_primary_10_1021_acs_analchem_8b04824 crossref_primary_10_1038_gt_2014_92 crossref_primary_10_1002_smll_201501914 crossref_primary_10_1016_j_xphs_2016_02_005 crossref_primary_10_1016_j_xphs_2016_03_044 crossref_primary_10_1371_journal_ppat_1005871 crossref_primary_10_2139_ssrn_4074424 crossref_primary_10_12688_f1000research_149068_1 crossref_primary_10_1016_j_chroma_2016_05_053 crossref_primary_10_1016_j_jchromb_2018_05_007 crossref_primary_10_1016_j_wroa_2022_100146 crossref_primary_10_1039_D1NR07607H crossref_primary_10_1002_jssc_201600765 crossref_primary_10_1186_s12951_021_01081_2 crossref_primary_10_1515_nanoph_2020_0330 crossref_primary_10_1088_1361_6501_acfab0 crossref_primary_10_3390_ijms22041842 crossref_primary_10_1016_j_chemosphere_2016_07_042 crossref_primary_10_1016_j_vaccine_2019_09_057 crossref_primary_10_3390_ijms24098081 crossref_primary_10_1016_j_jchromb_2015_04_004 crossref_primary_10_1021_acs_est_6b05835 crossref_primary_10_1021_acs_nanolett_2c00253 crossref_primary_10_1140_epjp_s13360_022_02995_y crossref_primary_10_1088_0957_4484_27_30_305603 crossref_primary_10_1002_jssc_201900441 crossref_primary_10_1002_aic_14349 crossref_primary_10_1016_j_aca_2017_11_066 crossref_primary_10_1186_s12977_015_0207_z crossref_primary_10_1080_14760584_2023_2299380 crossref_primary_10_1016_j_aca_2022_339633 crossref_primary_10_1016_j_virol_2014_06_005 crossref_primary_10_3389_fchem_2022_937180 crossref_primary_10_1021_acsnano_5b07948 crossref_primary_10_1021_acsnano_4c04396 crossref_primary_10_1016_j_ejpb_2018_08_006 crossref_primary_10_1038_srep33170 crossref_primary_10_1016_j_chroma_2016_12_085 crossref_primary_10_1038_s41586_024_07616_5 crossref_primary_10_1038_s41598_024_56297_7 crossref_primary_10_1002_ppsc_202200173 crossref_primary_10_1002_anie_201603007 crossref_primary_10_1016_j_vaccine_2019_07_050 crossref_primary_10_3390_v11100938 crossref_primary_10_1515_nanoph_2024_0139 crossref_primary_10_1089_hgtb_2017_052 crossref_primary_10_1021_acscentsci_7b00412 crossref_primary_10_1038_s41467_023_39021_3 crossref_primary_10_1007_s00216_018_1016_8 crossref_primary_10_1038_srep25275 crossref_primary_10_3390_v12020223 crossref_primary_10_3390_v13050939 crossref_primary_10_1002_jps_24510 crossref_primary_10_1016_j_ejpb_2016_04_013 crossref_primary_10_3390_bios14010020 crossref_primary_10_2217_nnm_2016_0103 crossref_primary_10_1016_j_jviromet_2017_06_002 crossref_primary_10_1038_s41598_020_75490_y crossref_primary_10_1371_journal_pone_0216247 crossref_primary_10_1021_acsanm_2c00886 crossref_primary_10_1016_j_vaccine_2019_07_001 crossref_primary_10_3390_biom10010119 crossref_primary_10_1002_ange_201603007 crossref_primary_10_1088_2057_1976_aad6d8 crossref_primary_10_1016_j_ijpharm_2024_124097 crossref_primary_10_1021_acssensors_9b00489 crossref_primary_10_1089_hgtb_2019_172 crossref_primary_10_1111_jam_15581 crossref_primary_10_1016_j_jddst_2022_103579 |
| Cites_doi | 10.1016/j.tibtech.2006.03.003 10.1016/j.ymthe.2005.02.021 10.1016/S0168-1702(02)00028-X 10.1016/j.bbagen.2005.06.006 10.1128/AEM.18.5.824-833.1969 10.1016/j.vaccine.2009.12.025 10.1016/S0378-4347(00)00557-0 10.1016/j.tim.2008.11.002 10.1016/S0734-9750(02)00030-7 10.1016/j.colsurfa.2011.07.020 10.1016/j.vaccine.2007.05.013 10.1016/j.vaccine.2009.07.007 10.1016/j.virusres.2005.01.009 10.1016/j.jviromet.2007.04.008 10.4049/jimmunol.151.11.6265 10.1007/s11095-010-0073-2 10.1016/j.brainres.2006.01.105 10.1084/jem.102.4.441 10.1016/j.vaccine.2010.03.029 10.1016/j.virusres.2007.10.005 10.1016/j.memsci.2007.04.048 10.1016/S0140-6736(04)15629-8 |
| ContentType | Journal Article |
| Copyright | Kramberger et al.; licensee BioMed Central Ltd. 2012 COPYRIGHT 2012 BioMed Central Ltd. 2012 Kramberger et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright ©2012 Kramberger et al.; licensee BioMed Central Ltd. 2012 Kramberger et al.; licensee BioMed Central Ltd. |
| Copyright_xml | – notice: Kramberger et al.; licensee BioMed Central Ltd. 2012 – notice: COPYRIGHT 2012 BioMed Central Ltd. – notice: 2012 Kramberger et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. – notice: Copyright ©2012 Kramberger et al.; licensee BioMed Central Ltd. 2012 Kramberger et al.; licensee BioMed Central Ltd. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7S9 L.6 5PM DOA |
| DOI | 10.1186/1743-422X-9-265 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1743-422X |
| EndPage | 265 |
| ExternalDocumentID | oai_doaj_org_article_0caefc4012ce4ee5bf9924554b60a2f1 PMC3503628 2821617511 A534300189 23140220 10_1186_1743_422X_9_265 |
| Genre | Evaluation Studies Journal Article Comparative Study |
| GeographicLocations | Slovenia |
| GeographicLocations_xml | – name: Slovenia |
| GroupedDBID | --- 0R~ 123 29Q 2VQ 2WC 4.4 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAHBH AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IGS IHR INH INR IPNFZ ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RIG RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7U9 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 7S9 L.6 5PM |
| ID | FETCH-LOGICAL-c761t-40bef9b52e181089ba447b9c7820b84840c80b94b49e80428857c8fcebc2f3d3 |
| IEDL.DBID | M48 |
| ISSN | 1743-422X |
| IngestDate | Wed Aug 27 01:05:13 EDT 2025 Thu Aug 21 14:04:04 EDT 2025 Fri Sep 05 02:45:29 EDT 2025 Fri Sep 05 13:41:32 EDT 2025 Thu Sep 04 16:40:32 EDT 2025 Fri Jul 25 06:59:23 EDT 2025 Tue Jun 17 22:05:45 EDT 2025 Tue Jun 10 21:03:35 EDT 2025 Fri Jun 27 05:57:38 EDT 2025 Thu Apr 03 07:01:53 EDT 2025 Thu Apr 24 23:10:16 EDT 2025 Tue Jul 01 01:44:38 EDT 2025 Sat Sep 06 07:30:02 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Adenovirus 5 NTA Latex particles CIM monolithic column Influenza NanoSight |
| Language | English |
| License | http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c761t-40bef9b52e181089ba447b9c7820b84840c80b94b49e80428857c8fcebc2f3d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/1743-422X-9-265 |
| PMID | 23140220 |
| PQID | 1179005993 |
| PQPubID | 55248 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_0caefc4012ce4ee5bf9924554b60a2f1 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3503628 proquest_miscellaneous_2985473769 proquest_miscellaneous_1328514595 proquest_miscellaneous_1197484899 proquest_journals_1179005993 gale_infotracmisc_A534300189 gale_infotracacademiconefile_A534300189 gale_incontextgauss_ISR_A534300189 pubmed_primary_23140220 crossref_citationtrail_10_1186_1743_422X_9_265 crossref_primary_10_1186_1743_422X_9_265 springer_journals_10_1186_1743_422X_9_265 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2012-11-12 |
| PublicationDateYYYYMMDD | 2012-11-12 |
| PublicationDate_xml | – month: 11 year: 2012 text: 2012-11-12 day: 12 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Virology journal |
| PublicationTitleAbbrev | Virol J |
| PublicationTitleAlternate | Virol J |
| PublicationYear | 2012 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | JC Hierholzer (1902_CR23) 1969; 18 B Lah (1902_CR21) 2008 FL Horsfall Jr (1902_CR26) 1955; 102 M Maeda (1902_CR5) 2006; 1081 V Filipe (1902_CR19) 2010; 27 SS Renteria (1902_CR16) 2010; 28 I Nadeau (1902_CR7) 2003; 20 JF Wright (1902_CR14) 2005; 12 O Kistner (1902_CR1) 2007; 25 AL Ru (1902_CR3) 2010; 28 JR Clark (1902_CR9) 2006; 24 JC Hierholzer (1902_CR24) 1996 OP Zoueva (1902_CR13) 2002; 85 ASTM E2834 (1902_CR20) 2012 W Fiers (1902_CR2) 2009; 27 ZC Hartman (1902_CR6) 2008; 132 RM Donlan (1902_CR10) 2009; 17 M Peterka (1902_CR22) 2011 R Miedzybrodzki (1902_CR11) 2005; 110 B Kalbfuss (1902_CR27) 2007; 299 KL Hartshorn (1902_CR17) 1993; 151 PM Ihnat (1902_CR15) 2005; 1726 U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM) (1902_CR25) 2001 C Roitsch (1902_CR4) 2001; 752 RD Boyd (1902_CR18) 2011; 387 J Bradbury (1902_CR8) 2004; 363 Z Wei (1902_CR12) 2007; 144 20044048 - Vaccine. 2010 Feb 25;28(9):2137-48 11270866 - J Chromatogr B Biomed Sci Appl. 2001 Mar 10;752(2):263-80 16567009 - Trends Biotechnol. 2006 May;24(5):212-8 15963933 - Mol Ther. 2005 Jul;12(1):171-8 20204471 - Pharm Res. 2010 May;27(5):796-810 20347632 - Vaccine. 2010 May 7;28(21):3661-71 4984203 - Appl Microbiol. 1969 Nov;18(5):824-33 13263486 - J Exp Med. 1955 Oct 1;102(4):441-73 16529724 - Brain Res. 2006 Apr 7;1081(1):34-43 8245465 - J Immunol. 1993 Dec 1;151(11):6265-73 19840661 - Vaccine. 2009 Oct 23;27(45):6280-3 14989277 - Lancet. 2004 Feb 21;363(9409):624-5 17614165 - Vaccine. 2007 Aug 10;25(32):6028-36 14550017 - Biotechnol Adv. 2003 Jan;20(7-8):475-89 17586059 - J Virol Methods. 2007 Sep;144(1-2):122-32 19162482 - Trends Microbiol. 2009 Feb;17(2):66-72 12034481 - Virus Res. 2002 May 10;85(2):141-9 15845250 - Virus Res. 2005 Jun;110(1-2):1-8 18036698 - Virus Res. 2008 Mar;132(1-2):1-14 16023295 - Biochim Biophys Acta. 2005 Nov 15;1726(2):138-51 |
| References_xml | – volume: 24 start-page: 212 year: 2006 ident: 1902_CR9 publication-title: Trends Biotechnol doi: 10.1016/j.tibtech.2006.03.003 – volume: 12 start-page: 171 issue: 1 year: 2005 ident: 1902_CR14 publication-title: Mol Ther doi: 10.1016/j.ymthe.2005.02.021 – volume: 85 start-page: 141 issue: 2 year: 2002 ident: 1902_CR13 publication-title: Virus Res doi: 10.1016/S0168-1702(02)00028-X – volume-title: Method for influenza virus purification year: 2011 ident: 1902_CR22 – volume: 1726 start-page: 138 issue: 2 year: 2005 ident: 1902_CR15 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbagen.2005.06.006 – volume: 18 start-page: 824 issue: 5 year: 1969 ident: 1902_CR23 publication-title: Appl Microbiol doi: 10.1128/AEM.18.5.824-833.1969 – volume: 28 start-page: 2137 year: 2010 ident: 1902_CR16 publication-title: Vaccine doi: 10.1016/j.vaccine.2009.12.025 – volume: 752 start-page: 263 issue: 2 year: 2001 ident: 1902_CR4 publication-title: J Chromatogr B doi: 10.1016/S0378-4347(00)00557-0 – volume: 17 start-page: 66 year: 2009 ident: 1902_CR10 publication-title: Trends Microbiol doi: 10.1016/j.tim.2008.11.002 – volume: 20 start-page: 475 issue: 7–8 year: 2003 ident: 1902_CR7 publication-title: Biotechnol Adv doi: 10.1016/S0734-9750(02)00030-7 – start-page: 17 volume-title: New chromatographic method on methacrylate monoliths used for adenoviral vectors purification year: 2008 ident: 1902_CR21 – volume: 387 start-page: 35 issue: 1–3 year: 2011 ident: 1902_CR18 publication-title: Colloid Surf A doi: 10.1016/j.colsurfa.2011.07.020 – volume: 25 start-page: 6028 issue: 32 year: 2007 ident: 1902_CR1 publication-title: Vaccine doi: 10.1016/j.vaccine.2007.05.013 – volume: 27 start-page: 6280 issue: 45 year: 2009 ident: 1902_CR2 publication-title: Vaccine doi: 10.1016/j.vaccine.2009.07.007 – volume: 110 start-page: 1 year: 2005 ident: 1902_CR11 publication-title: Virus Res doi: 10.1016/j.virusres.2005.01.009 – volume: 144 start-page: 122 issue: 1–2 year: 2007 ident: 1902_CR12 publication-title: J Virol Methods doi: 10.1016/j.jviromet.2007.04.008 – volume: 151 start-page: 6265 year: 1993 ident: 1902_CR17 publication-title: J Immunol doi: 10.4049/jimmunol.151.11.6265 – start-page: 41 volume-title: Virology Methods Manual year: 1996 ident: 1902_CR24 – volume: 27 start-page: 796 issue: 5 year: 2010 ident: 1902_CR19 publication-title: Pharm Res doi: 10.1007/s11095-010-0073-2 – volume: 1081 start-page: 34 issue: 1 year: 2006 ident: 1902_CR5 publication-title: Brain Res doi: 10.1016/j.brainres.2006.01.105 – volume-title: Guidance for Industry, Bioanalytical Method Validation year: 2001 ident: 1902_CR25 – volume: 102 start-page: 441 issue: 4 year: 1955 ident: 1902_CR26 publication-title: J Exp Med doi: 10.1084/jem.102.4.441 – volume: 28 start-page: 3661 year: 2010 ident: 1902_CR3 publication-title: Vaccine doi: 10.1016/j.vaccine.2010.03.029 – volume: 132 start-page: 1 issue: 1–2 year: 2008 ident: 1902_CR6 publication-title: Virus Res doi: 10.1016/j.virusres.2007.10.005 – volume: 299 start-page: 251 issue: 1–2 year: 2007 ident: 1902_CR27 publication-title: J Membrane Sci doi: 10.1016/j.memsci.2007.04.048 – start-page: 02 volume-title: Guide for Measurement of Particle Size Distribution of Nanomaterials in Suspension by Nanoparticle Tracking Analysis (NTA). Active Standard ASTM E2834 Developed by Subcommittee: E56.02 year: 2012 ident: 1902_CR20 – volume: 363 start-page: 624 year: 2004 ident: 1902_CR8 publication-title: Lancet doi: 10.1016/S0140-6736(04)15629-8 – reference: 11270866 - J Chromatogr B Biomed Sci Appl. 2001 Mar 10;752(2):263-80 – reference: 17614165 - Vaccine. 2007 Aug 10;25(32):6028-36 – reference: 14989277 - Lancet. 2004 Feb 21;363(9409):624-5 – reference: 14550017 - Biotechnol Adv. 2003 Jan;20(7-8):475-89 – reference: 15963933 - Mol Ther. 2005 Jul;12(1):171-8 – reference: 18036698 - Virus Res. 2008 Mar;132(1-2):1-14 – reference: 19162482 - Trends Microbiol. 2009 Feb;17(2):66-72 – reference: 16567009 - Trends Biotechnol. 2006 May;24(5):212-8 – reference: 4984203 - Appl Microbiol. 1969 Nov;18(5):824-33 – reference: 16023295 - Biochim Biophys Acta. 2005 Nov 15;1726(2):138-51 – reference: 19840661 - Vaccine. 2009 Oct 23;27(45):6280-3 – reference: 15845250 - Virus Res. 2005 Jun;110(1-2):1-8 – reference: 8245465 - J Immunol. 1993 Dec 1;151(11):6265-73 – reference: 16529724 - Brain Res. 2006 Apr 7;1081(1):34-43 – reference: 12034481 - Virus Res. 2002 May 10;85(2):141-9 – reference: 20347632 - Vaccine. 2010 May 7;28(21):3661-71 – reference: 13263486 - J Exp Med. 1955 Oct 1;102(4):441-73 – reference: 20204471 - Pharm Res. 2010 May;27(5):796-810 – reference: 20044048 - Vaccine. 2010 Feb 25;28(9):2137-48 – reference: 17586059 - J Virol Methods. 2007 Sep;144(1-2):122-32 |
| SSID | ssj0032679 |
| Score | 2.3153257 |
| Snippet | The NanoSight LM10 with Nanoparticle tracking analysis (NTA) software was evaluated for the quantification of latex particles, adenovirus 5, and influenza... Doc number: 265 Abstract: The NanoSight LM10 with Nanoparticle tracking analysis (NTA) software was evaluated for the quantification of latex particles,... Abstract The NanoSight LM10 with Nanoparticle tracking analysis (NTA) software was evaluated for the quantification of latex particles, adenovirus 5, and... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 265 |
| SubjectTerms | Adenoviridae Adenoviridae - isolation & purification Adenovirus Adenovirus 5 Adenoviruses Atoms & subatomic particles Biomedical and Life Sciences Biomedicine chromatography CIM monolithic column Comparative analysis computer software Diagnosis Gene therapy Health aspects hemagglutination Influenza Influenza virus Influenza viruses latex Latex particles Methodology Methods Nanoparticles NanoSight NTA Orthomyxoviridae Orthomyxoviridae - isolation & purification Polymerase chain reaction Process controls Reproducibility of Results Software Transmission electron microscopy Vaccines Viral Load - methods virion Virion - isolation & purification Virology Virus diseases Viruses |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJRAXBOUVKMggJOAQmvUr9rGgVgWpHGiR9mbZjg2VUIK6u0j8e2YSJ9oUCheu8ThRZiae-ZzxN4S8iA1HYjNZCq-rEjyEl0b5UIpmgc0YPbgQ7kOefFTHn8WHpVxutfrCmrCBHnhQ3H4VXEwBUAALUcQofTIAGSAIelU5lnrgU5lqBFPDGgw5Sc-yh-l2KRhbZlKfhVb707XSlAxjylY86mn7f1-ct6LT5crJS79P-6h0dJvcyukkPRhe4w65Fttdcn1oMPlzl9w4yb_O75LTw4nXm3aJtq4FuDxMo_CQgFvm1GWKEgqpLF13kJjTH-cXmxWdRJuxfAZvdI-cHR2evTsuc0eFMtRqsQaw6GMyXrIIgb3Sxjsham8CkuZ5LQDsBV15I7wwUSOa0rIOOoXoA0u84ffJTtu18SGhQjXRJ-a4l7UA1GOcqrwPxiQdpfOhIG9GtdqQ2cax6cU326MOrSzawaIdrLFgh4K8miZ8H4g2rhZ9i3aaxJAhu78AfmOzOuy__KYgz9HKFjkwWiyy-eI2q5V9f_rJHkguOHYrNAV5mYVSh6Zw-cwC6ABps2aSezNJ-EjDfHh0JpsXiRXyrJueH4cX5Nk0jDOx8K2N3QZlDLK9Air-iwxnkDcLaeTVMsxo7DJdK7jPg8GHJ_1Bii_wwHVB6pl3zxQ8H2nPv_ZU5FxiBqQL8nr8DrZe78_We_Q_rPeY3ITMleGh0AXbIzvri018Atnh2j_tF4Jflqdd8w priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCMQFQXkFCgoICTiEJn4k9gkV1KoglQMt0t6s2LFLJZSUzS4S_54ZxwmbQnuNx4kyM7a_scffEPLKNQyJzUTGjcwz8BCWqdLYjDcFFmM04EK4D3n0pTz8xj8vxCJuuPUxrXKcE8NE3XQW98h3kboskImw9-c_M6wahaersYTGdXIjUJeBP1eLKeACZBK49hB0Z5zSRaT2KWS5Oz3LVEZxZdlYlQJ5_79T9MYadTF_8sIhalibDu6SOxFUpnuDF9wj11y7TW4OZSZ_b5NbR_EA_T453p_YvdPOp23dQtA8dEvhIxY3ztM6EpWkAGjTVQfwPP11tlz36STajEk0-KIH5ORg_-TjYRbrKmS2KosVhIzGeWUEdbC851KZmvPKKIvUeUZyCPmszI3ihisnMaaSorLSW2cs9axhD8lW27XuMUl52Tjjac2MqDjEPqouc2OsUl46URubkHejWrWNnONY-uKHDrGHLDXaQaMdtNJgh4S8mTqcD3Qbl4t-QDtNYsiTHR50y1Md1aFzWztvIYak1nHnhPEKAk6AUKbMa-qLhLxEK2tkwmgx1ea0Xve9_nT8Ve8JxhnWLFQJeR2FfIemqOPNBdABkmfNJHdmkjBU7bx5dCYdp4pe_3XshLyYmrEnpr-1rlujjELOV4iNr5BhFNAzF0pcLkOVxFrTVQnveTT48KQ_APocr10npJp590zB85b27HsgJGcCcZBMyNtxHGz83v-t9-RqVTwltwGZUrz0WdAdsrVart0zQH8r8zwM8T8T8FS7 priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwELWgCNQLgvLRQEEGIQGHQOKv2MdStSpI5UCLtDcrdmyohBLU3UXi3zOTONGmtEhc18-JdmZsv4ntN4S8Cg1HYTOZC6eLHCKE50Y5n4umxGKMDkIIv0OefFbHX8WnhVwkkSS8C7O5f19q9R4Jcy4YW-QmZ0reJLdkyVW_K6sOxikXKEhlkm7PFZ1mS06vzP_3_LuxAF0-HHlph7RfeI7ukbuJMdL9wcX3yY3Q7pDbQw3J3zvkzknaHX9ATg8n6W7aRdrWLWTEQzcKL_H4VZzWSYWEAlulqw64N_11frFe0gnajCdk8EEPydnR4dnBcZ6KJuS-UuUK8kEXonGSBVi7C21cLUTljEddPKcF5HNeF84IJ0zQmDBpWXkdfXCeRd7wR2Sr7dqwS6hQTXCR1dzJSkBiY2pVOOeNiTrI2vmMvBvNan0SFMe6Fj9sn1hoZdEPFv1gjQU_ZOTN1OHnoKVxPfQD-mmCoQh2_wPEhk3msIWvQ_SQIDIfRAjSRQPZJPAjp4qaxTIjL9HLFmUuWjxH861eL5f24-kXuy-54FiQ0GTkdQLFDl1Rp2sJYANUxpoh92ZIGId-3jwGk03zwBKl1E0vgcMz8mJqxp54tq0N3RoxBgVdIfH9B4YzoMZCGnk9hhmNhaQrBc95PMTwZD9g8QLvVGekmkX3zMDzlvb8e682ziWSHJ2Rt-M42Ph7V3vvyX9gn5Jt4KAMr3eWbI9srS7W4RnwvJV73o_xP9JVSjo priority: 102 providerName: Springer Nature |
| Title | Evaluation of nanoparticle tracking analysis for total virus particle determination |
| URI | https://link.springer.com/article/10.1186/1743-422X-9-265 https://www.ncbi.nlm.nih.gov/pubmed/23140220 https://www.proquest.com/docview/1179005993 https://www.proquest.com/docview/1197484899 https://www.proquest.com/docview/1328514595 https://www.proquest.com/docview/2985473769 https://pubmed.ncbi.nlm.nih.gov/PMC3503628 https://doaj.org/article/0caefc4012ce4ee5bf9924554b60a2f1 |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED-xTSBeEIyvwKgCQgIeMlLHduwHhLaq00DqhPYh9c2KXWdMmhLoB2L_PXdpEprR8pj6nKj3kbuf7fwO4K2fJERsJiJuVRyhhySRltZFfNKnZowWXYjWIUcn8viCfx2L8d92QLUCZ2uhHfWTuphe7__-efMZA_5TFfBKfqSiOuKMjSMdMSm2YAfTkiQkNuLtlgKWKamuuX3WTCJS4ATBBqPG3ysZqiLy__d1vZKvbp-lvLWhWuWpo4fwoC4ww4OlRzyCO77YhbvLlpM3u3BvVG-mP4azYcv0HZZ5WGQFAujltBAf4mgRPcxq0pIQi9twXqKWwl9X08UsbEUnzYEautETOD8ang-Oo7rHQuRS2Z8jfLQ-11Ywj6k-VtpmnKdWO6LRs4oj_HMqtppbrr0ifKVE6lTuvHUsTybJU9guysI_h5DLibc5yxIrUo44SGcyttZpnSsvMusC2G_UalzNP05tMK5NhUOUNGQSQyYx2qBJAnjfTvixpN7YLHpIdmrFiDO7-qGcXppaHSZ2mc8d4knmPPde2Fwj-MRyyso4Y3k_gDdkZUOsGAUdu7nMFrOZ-XJ2ag5EwhPqX6gDeFcL5SWZIqu_YkAdEJFWR3KvI4lh67rDjTOZxuuJeV1XjDlJAK_bYZpJR-EKXy5IRhP_K-Lk_8gkDCtpLrTYLMO0or7TqcT7PFv6cKu_JhQCSDve3VFwd6S4-l6RkyeCaiIVwIcmDlb-3nrrvdj4_JdwHwtUVn37Ge_B9ny68K-wCJzbHmyl47QHO4fDk2-neDWQg161oNKrwv4Po89ZPQ |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrXhcEJRXoEBAIMohNOs4WfuAUAtb7dLuCrWLtDcrdpxSCSVlH6D-KP4jM3mxKbS3XuOxVzszHs_nxzcAr2wSELFZ6HEtfA89JPBkpI3Hky4VY9ToQrQPORpHg6_88zScrsHv-i0MXausY2IRqJPc0B75NlGXFWQiwYfTHx5VjaLT1bqERukW-_bsF0K2-fvhJ7Tva8b2-pOPA6-qKuAZhOwLBEzaplKHzOLi5gupY857WhoijtOCI-AxwteSay6tIEQhwp4RqbHasDRIAhz2GqxzetDagfXd_vjLYR36MRUqyP0oy_c4Y9OKS6grou3mmyc9RkvZyjJYVAv4d01YWRTPX9g8d2pbLIZ7d-B2lcW6O6Xb3YU1m23A9bKu5dkG3BhVJ_b34Kjf0Im7eepmcYYovezm4o8Y2ql344oZxcUM2l3kiAfcnyez5dxtRJP61g4NdB8mV6HyB9DJ8sw-ApdHidUpiwMd9jiCLRlHvtZGylTYMNbGgXe1WpWpSM6p1sZ3VYAdESmygyI7KKnQDg5sNR1OS36Pi0V3yU6NGBFzFx_y2bGq1KF8E9vUIGhlxnJrQ51KRLiYs-nIj1nadeAlWVkR9UZGd3uO4-V8roZHh2onDHhARRKlA28qoTQnU8TVUwnUAbF1tSQ3W5IYG0y7uXYmVcWmufo7kxx40TRTT7pvl9l8STKSSGYRjF8iEzBM1znOg4tlmBRU3LoX4TgPSx9u9IfIgtM7bwd6Le9uKbjdkp18KxjQg5ASL-HA23oerPy9_1vv8eWqeA43B5PRgToYjvefwC1Mixm9OO2yTegsZkv7FFPPhX5WTXgX1BWHmD_yaZHO |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fb9QwDI5giIkXBONXYUBBSMBDt16apMnjGDttwCbEhnRvUZMmYxJqp2sPif8eu02rdWxIvF6cVmc78efG-UzIG1dmSGzGE2ZkmoCHZIkSxiasnGEzRgMuhN8hD4_E_nf2acEXoTanGardhyPJ_k4DsjRV7fZ56fslLsU2wuiEUbpIVEIFv0luMYx7eFYrdoeNGIBJrgKbzxWTJoGo4-v_e1e-EJYul0xeOjftwtH8HrkbcGS80xv-Prnhqg1yu-8s-XuDrB-GM_MH5HhvJPSOax9XRQV5cj8thpdY_FYeF4GbJAYMG7c1IPL419ly1cSjaDnUzeCDHpKT-d7J7n4SWikkNhezFrJE47wynDqI6KlUpmAsN8oiW56RDLI8K1OjmGHKSUyjJM-t9NYZS31WZo_IWlVX7gmJmSid8bTIDM8ZpDuqEKkxVikvHS-MjcjWoFZtA804drv4qbt0QwqNdtBoB6002CEi78YJ5z3DxvWiH9BOoxhSY3c_1MtTHdShU1s4byFtpNYx57jxCnJMQE1GpAX1s4i8RitrJL-osLrmtFg1jT44_qZ3eMYybFOoIvI2CPkaTVGEywqgA-TLmkhuTiRhddrp8OBMOuwODRKsq44YJ4vIq3EYZ2LFW-XqFcoopHmFdPgfMhkFwMy44tfLUCWxvXQu4DmPex8e9QfYnuFN64jkE--eKHg6Up396DjIM47QR0bk_bAOLvy9q6339D9kX5L1rx_n-svB0edn5A6AVIr3P2d0k6y1y5V7DkCwNS-65f4HTxxVbg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+nanoparticle+tracking+analysis+for+total+virus+particle+determination&rft.jtitle=Virology+journal&rft.au=Kramberger%2C+Petra&rft.au=Ciringer%2C+Mateja&rft.au=%C5%A0trancar%2C+Ale%C5%A1&rft.au=Peterka%2C+Matja%C5%BE&rft.date=2012-11-12&rft.eissn=1743-422X&rft.volume=9&rft.spage=265&rft_id=info:doi/10.1186%2F1743-422X-9-265&rft_id=info%3Apmid%2F23140220&rft.externalDocID=23140220 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1743-422X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1743-422X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1743-422X&client=summon |